BIOMARIN PHARMACEUTICAL INC Gain (Loss) on Disposition of Other Assets
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Gain (Loss) on Disposition of Other Assets of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-26.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2024-02-26
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for the quarter ending 2023-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for the quarter ending 2023-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for the quarter ending 2023-06-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for fiscal 2022 was $108.00M.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- BIOMARIN PHARMACEUTICAL INC gain (loss) on disposition of other assets for fiscal 2020 was $52.82M, a 111.28% increase from fiscal 2019.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 12 month | Gain (Loss) on Disposition of Other Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-02-26 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $0.00 derived: sum of 4 quarters · filed 2024-02-26 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $0.00 derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $108.00M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $108.00M 10-Q · filed 2023-11-02 | $108.00M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $108.00M 10-Q · filed 2023-08-02 | $108.00M derived: sum of 3 quarters · filed 2024-02-26 | $108.00M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2022-03-31 | $108.00M 10-Q · filed 2023-04-28 | $108.00M derived: sum of 2 quarters · filed 2024-02-26 | $108.00M derived: sum of 3 quarters · filed 2024-02-26 | $108.00M derived: sum of 4 quarters · filed 2024-02-26 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $0.00 10-K · filed 2024-02-26 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $0.00 10-Q · filed 2022-10-28 | -$6.67M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$6.67M derived: sum of 3 quarters · filed 2023-02-27 | -$6.67M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-30 | -$6.67M derived: sum of 2 quarters · filed 2023-02-27 | -$6.67M derived: sum of 3 quarters · filed 2023-02-27 | -$6.67M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$6.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$6.67M derived: sum of 2 quarters · filed 2023-02-27 | -$6.67M derived: sum of 3 quarters · filed 2023-02-27 | $52.82M 10-K · filed 2023-02-27 | $59.49M 10-K · filed 2021-02-26 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | $59.49M 10-Q · filed 2021-10-29 | $69.50M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $59.49M 10-Q · filed 2021-07-30 | $69.50M derived: sum of 3 quarters · filed 2022-02-25 | $69.50M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $59.49M 10-Q · filed 2021-04-30 | $69.50M derived: sum of 2 quarters · filed 2022-02-25 | $69.50M derived: sum of 3 quarters · filed 2022-02-25 | $84.50M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $10.00M derived: sum of 2 quarters · filed 2022-02-25 | $25.00M derived: sum of 3 quarters · filed 2022-02-25 | $25.00M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $15.00M derived: sum of 2 quarters · filed 2020-11-06 | $15.00M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $15.00M 10-Q · filed 2020-08-05 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-01 | ||||
| 2018-12-31 | $50.00M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |